Lymphoproliferative Disorders
"Lymphoproliferative Disorders" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Disorders characterized by proliferation of lymphoid tissue, general or unspecified.
| Descriptor ID |
D008232
|
| MeSH Number(s) |
C15.604.515 C20.683.515
|
| Concept/Terms |
Lymphoproliferative Disorders- Lymphoproliferative Disorders
- Disorder, Lymphoproliferative
- Disorders, Lymphoproliferative
- Lymphoproliferative Disorder
X-Linked Lymphoproliferative Disorder- X-Linked Lymphoproliferative Disorder
- Disorder, X-Linked Lymphoproliferative
- Disorders, X-Linked Lymphoproliferative
- Lymphoproliferative Disorder, X-Linked
- Lymphoproliferative Disorders, X-Linked
- X Linked Lymphoproliferative Disorder
- X-Linked Lymphoproliferative Disorders
- Epstein-Barr Virus Infection, Familial Fatal
- Epstein Barr Virus Infection, Familial Fatal
- Epstein-Barr Virus-Induced Lymphoproliferative Disease In Males
- Epstein Barr Virus Induced Lymphoproliferative Disease In Males
- Familial Fatal Epstein-Barr Infection
- Familial Fatal Epstein Barr Infection
- Immunodeficiency 5
- Immunodeficiency 5s
- Duncan's Syndrome
- Lymphoproliferative Disease, X-Linked
- Disease, X-Linked Lymphoproliferative
- Diseases, X-Linked Lymphoproliferative
- Lymphoproliferative Disease, X Linked
- Lymphoproliferative Diseases, X-Linked
- X-Linked Lymphoproliferative Diseases
- Lymphoproliferative Syndrome, X-Linked, 1
- Purtilo Syndrome
- Purtilo Syndromes
- Syndrome, Purtilo
- Syndromes, Purtilo
- X-Linked Lymphoproliferative Disease
- X Linked Lymphoproliferative Disease
- X-Linked Lymphoproliferative Syndrome
- Lymphoproliferative Syndrome, X-Linked
- Lymphoproliferative Syndromes, X-Linked
- Syndrome, X-Linked Lymphoproliferative
- Syndromes, X-Linked Lymphoproliferative
- X Linked Lymphoproliferative Syndrome
- X-Linked Lymphoproliferative Syndromes
- Duncan Disease
- Disease, Duncan
- Immunodeficiency, X-Linked Progressive Combined Variable
- Immunodeficiency, X Linked Progressive Combined Variable
|
Below are MeSH descriptors whose meaning is more general than "Lymphoproliferative Disorders".
Below are MeSH descriptors whose meaning is more specific than "Lymphoproliferative Disorders".
This graph shows the total number of publications written about "Lymphoproliferative Disorders" by people in this website by year, and whether "Lymphoproliferative Disorders" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 1995 | 1 | 1 | 2 |
| 1996 | 2 | 1 | 3 |
| 1997 | 5 | 1 | 6 |
| 1998 | 3 | 0 | 3 |
| 1999 | 7 | 2 | 9 |
| 2000 | 2 | 3 | 5 |
| 2001 | 3 | 2 | 5 |
| 2002 | 2 | 2 | 4 |
| 2003 | 1 | 1 | 2 |
| 2005 | 4 | 1 | 5 |
| 2006 | 1 | 1 | 2 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 1 | 2 |
| 2009 | 2 | 2 | 4 |
| 2010 | 3 | 1 | 4 |
| 2011 | 3 | 2 | 5 |
| 2013 | 2 | 0 | 2 |
| 2014 | 2 | 0 | 2 |
| 2015 | 4 | 0 | 4 |
| 2016 | 1 | 0 | 1 |
| 2019 | 2 | 0 | 2 |
| 2020 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lymphoproliferative Disorders" by people in Profiles.
-
Tabelecleucel for EBV+ PTLD after allogeneic HCT or SOT in a multicenter expanded access protocol. Blood Adv. 2024 06 25; 8(12):3001-3012.
-
Peripheral T-cell lymphoma with TFH phenotype and associated indolent T-lymphoblastic proliferation. Blood. 2023 08 03; 142(5):493.
-
Idiopathic pulmonary fibrosis lung transplant recipients are at increased risk for EBV-associated posttransplant lymphoproliferative disorder and worse survival. Am J Transplant. 2020 05; 20(5):1439-1446.
-
The Morphologic Features of Primary Epstein-Barr Virus Infection in the Gastrointestinal Tract: An Approach to Correct Diagnosis. Am J Surg Pathol. 2019 09; 43(9):1253-1263.
-
Prophylactic rituximab prevents EBV PTLD in haplo-cord transplant recipients at high risk. Leuk Lymphoma. 2019 07; 60(7):1693-1696.
-
HLA: revisiting an old suspect in the complex pathogenesis of posttransplant lymphoproliferative disorders. Leuk Lymphoma. 2016 10; 57(10):2241-2.
-
Characterization of primary cutaneous CD8+/CD30+ lymphoproliferative disorders. Am J Dermatopathol. 2015 Nov; 37(11):822-33.
-
Single-Fraction Radiotherapy for CD30(+) Lymphoproliferative Disorders. Biomed Res Int. 2015; 2015:629587.
-
Susceptibility-weighted imaging and diffusion-weighted imaging findings in central nervous system monomorphic B cell post-transplant lymphoproliferative disorder before and after treatment and comparison with primary B cell central nervous system lymphoma. J Neurooncol. 2015 Nov; 125(2):297-305.
-
Mutlifocal osseous posttransplantation lymphoproliferative disorder: case report. Skeletal Radiol. 2015 Jul; 44(7):1021-6.